00950 LEE'S PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.02X | Oper Margin | 8.1% |
|---|---|---|---|
| LT Debt/Equity | 4.2% | Net Margin | 6.7% |
| Total Debt/Equity | 13.8% | Return on Equity | 5.6% |
| Price/Book | 0.77X | Return on Assets | 3.6% |
| (HKD 2.160) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 93.10 | 16.70 | 51.28 | 1,987.18 | 129.32 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +457.6 | -67.4 | -97.4 | +1,436.7 | +3.0 |
| Earnings Per Share (HKD) | 0.158 | 0.028 | 0.087 | 3.376 | 0.22 |
| Earnings Per Share Growth (%) | +456.7 | -67.4 | -97.4 | +1,435.2 | +3.6 |
| Dividend Per Share (HKD) | 0.045 | 0.018 | 0.020 | 0.061 | 0.058 |
| P/E* (X) | 13.66 | 76.06 | 24.80 | 0.64 | 9.82 |
| Yield (%) | 2.08 | 0.83 | 0.93 | 2.82 | 2.69 |
| Dividend Share (%) | 28.46 | 63.38 | 22.96 | 1.81 | 26.38 |
| Book NAV (HKD) | 2.805 | 3.463 | 3.268 | 4.186 | 3.655 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 694.821 | 658.345 | +5.5 | 512.308 |
| Operating Result | 61.163 | 61.347 | -0.3 | 27.628 |
| Associates | -0.488 | -0.239 | +104.2 | -0.44 |
| Profit Before Taxation | 60.675 | 61.108 | -0.7 | 27.188 |
| Taxation | 10.129 | 6.239 | +62.3 | 6.279 |
| Profit /( Loss) After Taxation | 50.546 | 54.869 | -7.9 | 20.909 |
| Minority Interests | -16.639 | -7.609 | +118.7 | 4.792 |
| Net Profit | 67.185 | 62.478 | +7.5 | 16.117 |
| Earnings Per Share () | 0.1141 | 0.1061 | +7.5 | 0.0274 |
| Dividend Per Share () | 0.0220 | 0.0200 | +10.0 | 0.0080 |
| Announcement Date | 2025-08-26 | 2024-08-28 | NA | 2023-08-30 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
